Bimin Shi Selected Research

Bimin Shi Research Topics

Disease

11	Type 2 Diabetes Mellitus (MODY) 11/2023 - 01/2014
5	Insulin Resistance 01/2022 - 10/2015
4	Body Weight (Weight, Body) 11/2023 - 01/2014
3	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2020
3	Obesity 01/2020 - 01/2019
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2024 - 09/2016
2	Carotid Artery Diseases 06/2022 - 01/2022
2	Inflammation (Inflammations) 09/2019 - 01/2018
2	Overweight 01/2019 - 06/2018
1	Diarrhea 11/2023
1	Nausea 11/2023
1	Vomiting 11/2023
1	Hypoglycemia (Reactive Hypoglycemia) 11/2023
1	Hypertrophy 06/2023
1	Fibrosis (Cirrhosis) 06/2023
1	Heart Failure 06/2023
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2023
1	Diabetic Nephropathies (Diabetic Nephropathy) 05/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Fatty Liver 01/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2022
1	Albuminuria 03/2021
1	Hypotension (Low Blood Pressure) 03/2021
1	Weight Loss (Weight Reduction) 02/2021
1	Hypothyroidism 01/2021
1	Hyperthyroidism 01/2021
1	Ulcer 01/2021
1	Thyroid Diseases (Thyroid Disease) 01/2021
1	Neuralgia (Stump Neuralgia) 12/2020
1	Pain (Aches) 12/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2019
1	Peptic Ulcer (Peptic Ulcers) 09/2019
1	Metabolic Diseases (Metabolic Disease) 01/2019
1	Weight Gain 01/2019
1	Thyroid Nodule (Nodule, Thyroid) 06/2018
1	Neoplasms (Cancer) 01/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Critical Illness (Critically Ill) 01/2018
1	Sepsis (Septicemia) 01/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Glucose Metabolism Disorders 01/2018
1	Infections 01/2018

Drug/Important Bio-Agent (IBA)

4	Insulin (Novolin)FDA Link 01/2023 - 01/2018
4	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2018
3	Metformin (Glucophage)FDA LinkGeneric 11/2023 - 01/2018
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2023 - 01/2021
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023 - 06/2018
2	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
2	CreatinineIBA 03/2021 - 01/2019
2	Blood Glucose (Blood Sugar)IBA 01/2019 - 01/2018
2	LipidsIBA 01/2019 - 01/2018
2	Insulin Glargine (Lantus)FDA Link 06/2018 - 01/2018
1	LigandsIBA 04/2024
1	Glucagon Receptors (Glucagon Receptor)IBA 11/2023
1	mazdutideIBA 11/2023
1	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2023
1	dulaglutideIBA 11/2023
1	CytokinesIBA 06/2023
1	Therapeutic UsesIBA 06/2023
1	Sodium-Glucose Transport ProteinsIBA 06/2023
1	dapagliflozinIBA 06/2023
1	empagliflozinIBA 01/2023
1	Beclin-1IBA 05/2022
1	TenascinIBA 01/2022
1	growth arrest-specific protein 6IBA 01/2022
1	alarinIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	NAD (NADH)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	C-PeptideIBA 03/2021
1	CholesterolIBA 02/2021
1	ON101IBA 01/2021
1	GlucokinaseIBA 01/2021
1	Cystatin CIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 12/2020
1	Interleukin-6 (Interleukin 6)IBA 12/2020
1	Phospholipases (Phospholipase)IBA 01/2020
1	Galectins (Galectin)IBA 01/2020
1	CarbenoxoloneIBA 09/2019
1	Chemotactic FactorsIBA 01/2019
1	saxagliptin FDA Link 01/2019
1	AlbuminsIBA 01/2019
1	glimepiride (Amarel)FDA LinkGeneric 01/2019
1	Polidocanol (Laureth)FDA Link 06/2018
1	Ethanol (Ethyl Alcohol)IBA 06/2018
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2018
1	Thyroid HormonesIBA 01/2018
1	NeuropeptidesIBA 01/2018
1	Exenatide (Byetta)FDA Link 01/2018
1	AutoantibodiesIBA 09/2016
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 10/2015
1	Glycogen Synthase (Synthase I)IBA 10/2015
1	PalmitatesIBA 10/2015
1	p38 Mitogen-Activated Protein KinasesIBA 10/2015

Therapy/Procedure

2	Glycemic Control 03/2021 - 01/2014
2	Therapeutics 01/2019 - 01/2019
1	Sclerotherapy 06/2018
1	Cell Transplantation 01/2018